Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Cohorts of a minimum of five patients each were treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback